Erina Shan is an experienced finance professional with a strong focus on biopharma and healthcare sectors. Currently serving as an Investor in Credit and Structured Capital at Viking Global Investors since 2023, Erina previously held the role of Senior Associate at Athyrium Capital Management, LP from 2020 to 2023, where work concentrated on biopharma and healthcare investment strategies. Prior experience includes an Associate position at Athyrium and an Analyst role in M&A Advisory at PJT Partners, specializing in Pharma and Biotech M&A from 2017 to 2020. Erina Shan holds a Bachelor of Arts in Chemistry from the University of Pennsylvania and a Bachelor of Science in Economics from The Wharton School.